A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

Recruiting

Phase 3

HBS-301A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

Sponsor:

Harmony Biosciences Management, Inc.

Code:

NCT07500090

Conditions

Idiopathic Hypersomnia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HBS-301 tablet

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-19. This information was provided to ClinicalTrials.gov by Harmony Biosciences Management, Inc. on 2026-03-30.